These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 8712922

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G, Cann AJ, Hauptmann R, Mountford RC, Clarke LD, Reeve P, Minor PD, Schild GC, Almond JW.
    Eur J Biochem; 1983 Oct 03; 135(3):529-33. PubMed ID: 6311539
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Wild poliovirus circulation among healthy children immunized with oral polio vaccine in Antananarivo, Madagascar.
    Andrianarivelo MR, Rabarijaona L, Boisier P, Chezzi C, Zeller HG.
    Trop Med Int Health; 1999 Jan 03; 4(1):50-7. PubMed ID: 10203174
    [Abstract] [Full Text] [Related]

  • 26. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion.
    Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Nagata N, Kew O, Miyamura T.
    Dev Biol (Basel); 2001 Jan 03; 105():93-8. PubMed ID: 11763343
    [Abstract] [Full Text] [Related]

  • 27. Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus.
    Georgescu MM, Delpeyroux F, Crainic R.
    J Gen Virol; 1995 Sep 03; 76 ( Pt 9)():2343-8. PubMed ID: 7561775
    [Abstract] [Full Text] [Related]

  • 28. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
    Zhang Y, Wang H, Zhu S, Li Y, Song L, Liu Y, Liu G, Nishimura Y, Chen L, Yan D, Wang D, An H, Shimizu H, Xu A, Xu W.
    J Gen Virol; 2010 Feb 03; 91(Pt 2):421-9. PubMed ID: 19846676
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil.
    Friedrich F, Filippis AM, Ferreira FC, Schatzmayr HG, Da Silva EE.
    Acta Virol; 1995 Feb 03; 39(1):23-9. PubMed ID: 7572466
    [Abstract] [Full Text] [Related]

  • 33. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.
    Evans DM, Dunn G, Minor PD, Schild GC, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV.
    Nature; 1995 Feb 03; 314(6011):548-50. PubMed ID: 2986004
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long-term excretion of vaccine-derived poliovirus by a healthy child.
    Martín J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, Fitzharris C, Butler K, Hall WW, Minor PD.
    J Virol; 2004 Dec 03; 78(24):13839-47. PubMed ID: 15564492
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.
    Arita M, Zhu SL, Yoshida H, Yoneyama T, Miyamura T, Shimizu H.
    J Virol; 2005 Oct 03; 79(20):12650-7. PubMed ID: 16188967
    [Abstract] [Full Text] [Related]

  • 39. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.
    Rahimi P, Tabatabaie H, Gouya MM, Zahraie M, Mahmudi M, Ziaie A, Rad KS, Shahmahmudi Sh, Musavi T, Azad TM, Nategh R.
    J Clin Virol; 2007 Aug 03; 39(4):304-7. PubMed ID: 17590391
    [Abstract] [Full Text] [Related]

  • 40. Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
    Martin J, Burns CC, Jorba J, Shulman LM, Macadam A, Klapsa D, Majumdar M, Bullows J, Frolov A, Mate R, Bujaki E, Castro CJ, Bullard K, Konz J, Hawes K, Gauld J, Blake IM, Mercer LD, Kurji F, Voorman A, Diop OM, Oberste MS, Modlin J, Macklin G, Eisenhawer M, Bandyopadhyay AS, Zipursky S.
    MMWR Morb Mortal Wkly Rep; 2022 Jun 17; 71(24):786-790. PubMed ID: 35709073
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.